| Hans-Günter Meyer-Thompson | Hepatitiden
Impact of direct-acting antiviral use for chronic hepatitis C on health care costs in Medicaid: economic model update.
Impact of direct-acting antiviral use for chronic hepatitis C on health care costs in Medicaid: economic model update.
Roebuck MC.
Am J Manag Care. 2022 Dec;28(12):630-631. doi: 10.37765/ajmc.2022.89273. PMID: 36525655.
https://www.ajmc.com/view/impact-of-direct-acting-antiviral-use-for-chronic-hepatitis-c-on-health-care-costs-in-medicaid-economic-model-update